Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Timeline
  • Published:

Innate immune sensing and its roots: the story of endotoxin

Nature Reviews Immunology volume 3, pages 169–176 (2003)Cite this article

Abstract

How does the host sense pathogens? Our present concepts grew directly from longstanding efforts to understand infectious disease: how microbes harm the host, what molecules are sensed and, ultimately, the nature of the receptors that the host uses. The discovery of the host sensors — the Toll-like receptors — was rooted in chemical, biological and genetic analyses that centred on a bacterial poison, termed endotoxin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Hippocrates and Galenos, the leading medical doctors of their times and creators of the theory that many diseases are of poisonous origin.
Figure 2: A Gram-negative bacterium.
Figure 3: LPS signalling.

References

  1. Magendie, F. Remarques sur la notice précédente (de Dupre), avec quelque expériences sur les effets des substances en putréfaction. J. Physiol. (Paris) 3, 81–88 (1823).

    Google Scholar 

  2. Westphal, O., Westphal, U. & Sommer, T. in Microbiology -1977 (ed. Schlessinger, D.) 221–238 (American Society of Microbiology, Washington DC, 1977).

    Google Scholar 

  3. Panum, P. L. Das putride Gift, die Bakterien, die putride Infektion oder Intoxikation und die Septikämie (The putrid poison, the bacteria, the putrid infection or intoxication and the septicaemia). Arch. Pathol. Anat. Physiol. Klin. Med. (Virchow's Arch.) 60, 301–352 (1874).

    Article  Google Scholar 

  4. Bergmann, E. & Schmiedeberg, O. Ueber das schwefelsaure Sepsin (das Gift faulender Substanzen). Centralbl. Med. Wissenschaften 32, 497–498 (1868).

    Google Scholar 

  5. Henle, J. in Klassiker der Medizin Vol. 3 (ed. Sudhoff, K.) 1–88 (Joh. Ambrosius Barth, Leipzig, 1910).

    Google Scholar 

  6. Latour, B. Pasteur — Une Science, Un Style, Un Siècle (Libraire Académique, Perrin, Paris, 1994).

    Google Scholar 

  7. Brock, D. Th. Robert Koch. A Life in Medicine and Bacteriology (Springer Verlag, Munich, 1988).

    Google Scholar 

  8. Brieger, L. Untersuchungen über Ptomaine Part III (Hirschwald, Berlin, 1886).

    Google Scholar 

  9. Koch, R. R. Koch's Vortrag über die Cholera. Fortschr. Med. 16, 121–135 (1884).

    Google Scholar 

  10. Koch, R. R. Koch's Vortrag über die Cholera. Fortschr. Med. 17, 141–169 (1884).

    Google Scholar 

  11. Pfeiffer, R. Weitere Untersuchungen über das Wesen der Choleraimmunität und über spezifisch bacterizide Prozesse. Z. Hyg. 18, 1–16 (1894).

    Article  Google Scholar 

  12. Pfeiffer, R. Untersuchungen über das Choleragift. Z. Hyg. 11, 393–411 (1892).

    Article  Google Scholar 

  13. Wolff, A. Über Grundgesetze der Immunität. Zentralbl. Bakteriol. 37, 390–397 (1904).

    Google Scholar 

  14. Rietschel, E. Th. & Cavaillon, J. -M. Endotoxin and anti-endotoxin. The contribution of the schools of Koch and Pasteur: life, milestone-experiments and concepts of Richard Pfeiffer (Berlin) and Alexandre Besredka (Paris). Historical perspective. J. Endotoxin Res. 8, 3–16; 71–82 (2002).

    Article  CAS  PubMed  Google Scholar 

  15. Rietschel, E. Th. & Westphal, O. in Endotoxin in Health and Disease (eds Brade, H., Opal, S. M., Vogel, S. N. & Morrison, D. C.) 1–29 (Marcel Dekker, New York, 1999).

    Google Scholar 

  16. Centanni, E. Untersuchungen über das Infektionsfieber – das Fiebergift der Bakterien. Dtsch. Med. Wochenschr. 20, 148–153 (1894).

    Article  Google Scholar 

  17. Coley-Nauts, H., Swift, W. E. & Coley, B. L. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M. D., revised in the light of modern research. Cancer Res. 6, 205–216 (1946).

    Google Scholar 

  18. Shear, M. J. & Turner, F. C. Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrates. J. Natl Cancer Inst. 4, 81–97 (1943).

    CAS  Google Scholar 

  19. Raetz, R. H. & Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635–700 (2002).

    Article  CAS  PubMed  Google Scholar 

  20. Galanos, C. et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148, 1–5 (1985).

    Article  CAS  PubMed  Google Scholar 

  21. Schromm, A. B. et al. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J. Immunol. 161, 5464–5471 (1998).

    CAS  PubMed  Google Scholar 

  22. Ferguson, A. D., Hofmann, E., Coulton, J. W., Diederichs, K. & Welte, W. Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science 282, 2215–2220 (1998).

    Article  CAS  PubMed  Google Scholar 

  23. Mühlradt, P. F., Kiess, M., Meyer, H., Süssmuth, R. & Jung, G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185, 1951–1958 (1997).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Weidemann, B. et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect. Immun. 65, 858–864 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Morath, S., Geyer, A. & Hartung, T. Structure–function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193, 393–398 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Wagner, H. Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr. Opin. Microbiol. 5, 62–69 (2002).

    Article  CAS  PubMed  Google Scholar 

  27. Heppner, G. & Weiss, D. W. High susceptibility of strain A mice to endotoxin and endotoxin–red blood cell mixtures. J. Bacteriol. 90, 696–703 (1965).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Watson, J. & Riblet, R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J. Exp. Med. 140, 1147–1161 (1974).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Watson, J. & Riblet, R. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipopolysaccharides. J. Immunol. 114, 1462–1468 (1975).

    CAS  PubMed  Google Scholar 

  30. Coutinho, A., Forni, L., Melchers, F. & Watanabe, T. Genetic defect in responsiveness to the B-cell mitogen lipopolysaccharide. Eur. J. Immunol. 7, 325–328 (1977).

    Article  CAS  PubMed  Google Scholar 

  31. Coutinho, A., Forni, L. & Watanabe, T. Genetic and functional characterization of an antiserum to the lipid A-specific triggering receptor on murine B lymphocytes. Eur. J. Immunol. 8, 63–67 (1978).

    Article  CAS  PubMed  Google Scholar 

  32. Moore, R. N., Goodrum, K. J. & Berry, L. J. Mediation of an endotoxic effect by macrophages. J. Reticuloendothel. Soc. 19, 187–197 (1976).

    CAS  PubMed  Google Scholar 

  33. Michalek, S. M., Moore, R. N., McGhee, J. R., Rosenstreich, D. L. & Mergenhagen, S. E. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J. Infect. Dis. 141, 55–63 (1980).

    Article  CAS  PubMed  Google Scholar 

  34. Finkelstein, R. A. Observations on mode of action of endotoxin in chick embryos. Proc. Soc. Exp. Biol. Med. 115, 702–707 (1964).

    Article  CAS  PubMed  Google Scholar 

  35. Berczi, I., Bertok, L. & Bereznai, T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can. J. Microbiol. 12, 1070–1071 (1966).

    Article  CAS  PubMed  Google Scholar 

  36. Berger, F. M. The effect of endotoxin on resistance to infection and disease. Adv. Pharmacol. 5, 19–46 (1967).

    Article  CAS  PubMed  Google Scholar 

  37. Neter, E. Endotoxins and the immune response. Curr. Top. Microbiol. Immunol. 47, 82–124 (1969).

    Article  CAS  PubMed  Google Scholar 

  38. O'Brien, A. D. et al. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol. 124, 20–24 (1980).

    CAS  PubMed  Google Scholar 

  39. Rosenstreich, D. L., Weinblatt, A. C. & O'Brien, A. D. Genetic control of resistance to infection in mice. CRC Crit. Rev. Immunol. 3, 263–330 (1982).

    CAS  Google Scholar 

  40. Hagberg, L. et al. Difference in susceptibility to Gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46, 839–844 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Woods, J. P., Frelinger, J. A., Warrack, G. & Cannon, J. G. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect. Immun. 56, 1950–1955 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Macela, A. et al. The immune response against Francisella tularensis live vaccine strain in Lpsn and Lpsd mice. FEMS Immunol. Med. Microbiol. 13, 235–238 (1996).

    Article  CAS  PubMed  Google Scholar 

  43. Mitchell, C. R., Kempton, J. B., Scott-Tyler, B. & Trune, D. R. Otitis media incidence and impact on the auditory brain stem response in lipopolysaccharide-nonresponsive C3H/HeJ mice. Otolaryngol. Head Neck Surg. 117, 459–464 (1997).

    Article  CAS  PubMed  Google Scholar 

  44. Beutler, B. et al. Identity of tumour-necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552–554 (1985).

    Article  CAS  PubMed  Google Scholar 

  45. Beutler, B., Milsark, I. W. & Cerami, A. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 229, 869–871 (1985).

    Article  CAS  PubMed  Google Scholar 

  46. Havell, E. A. Production of tumor necrosis factor during murine listeriosis. J. Immunol. 139, 4225–4231 (1987).

    CAS  PubMed  Google Scholar 

  47. Kindler, V., Sappino, A. -P., Grau, G. E., Piguet, P. -F. & Vassalli, P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56, 731–740 (1989).

    Article  CAS  PubMed  Google Scholar 

  48. Blanchard, D. K., Djeu, J. Y., Klein, T. W., Friedman, H. & Stewart, W. E. II. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J. Leukocyte Biol. 43, 429–435 (1988).

    Article  CAS  PubMed  Google Scholar 

  49. Cross, A. S., Sadoff, J. C., Kelly, N., Bernton, E. & Gemski, P. Pretreatment with recombinant murine tumor necrosis factor-α/cachectin and murine interleukin-1α protects mice from lethal bacterial infection. J. Exp. Med. 169, 2021–2027 (1989).

    Article  CAS  PubMed  Google Scholar 

  50. Desiderio, J. V., Kiener, P. A., Lin, P. F. & Warr, G. A. Protection of mice against Listeria monocytogenes infection by recombinant human tumor necrosis factor-α. Infect. Immun. 57, 1615–1617 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Sultzer, B. M. Genetic control of leucocyte responses to endotoxin. Nature 219, 1253–1254 (1968).

    Article  CAS  PubMed  Google Scholar 

  52. Butler, L. D. et al. Interleukin-1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clin. Immunol. Immunopathol. 53, 400–421 (1989).

    Article  CAS  PubMed  Google Scholar 

  53. Car, B. D. et al. Interferon-γ receptor-deficient mice are resistant to endotoxic shock. J. Exp. Med. 179, 1437–1444 (1994).

    Article  CAS  PubMed  Google Scholar 

  54. Tobias, P. S., Soldau, K. & Ulevitch, R. J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164, 777–793 (1986).

    Article  CAS  PubMed  Google Scholar 

  55. Tobias, P. S., Mathison, J. C. & Ulevitch, R. J. A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J. Biol. Chem. 263, 13479–13481 (1988).

    CAS  PubMed  Google Scholar 

  56. Wright, S. D., Tobias, P. S., Ulevitch, R. J. & Ramos, R. A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170, 1231–1241 (1989).

    Article  CAS  PubMed  Google Scholar 

  57. Schumann, R. R. et al. Structure and function of lipopolysaccharide binding protein. Science 249, 1429–1431 (1990).

    Article  CAS  PubMed  Google Scholar 

  58. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. & Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431–1433 (1990).

    Article  CAS  PubMed  Google Scholar 

  59. Shakhov, A. N., Collart, M. A., Vassalli, P., Nedospasov, S. A. & Jongeneel, C. V. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor-α gene in primary macrophages. J. Exp. Med. 171, 35–47 (1990).

    Article  CAS  PubMed  Google Scholar 

  60. Han, J., Lee, J. D., Bibbs, L. & Ulevitch, R. J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808–811 (1994).

    Article  CAS  PubMed  Google Scholar 

  61. Hambleton, J., Weinstein, S. L., Lem, L. & DeFranco, A. L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl Acad. Sci. USA 93, 2774–2778 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Herrera-Velit, P. & Reiner, N. E. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes. J. Immunol. 156, 1157–1165 (1996).

    CAS  PubMed  Google Scholar 

  63. Herrera-Velit, P., Knutson, K. L. & Reiner, N. E. Phosphatidylinositol 3-kinase-dependent activation of protein kinase Cζ in bacterial lipopolysaccharide-treated human monocytes. J. Biol. Chem. 272, 16445–16452 (1997).

    Article  CAS  PubMed  Google Scholar 

  64. Poltorak, A. et al. Genetic and physical mapping of the Lps locus — identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24, 340–355 (1998).

    Article  CAS  PubMed  Google Scholar 

  65. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).

    Article  CAS  PubMed  Google Scholar 

  66. Anderson, K. V., Bokla, L. & Nusslein-Volhard, C. Establishment of dorsal–ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42, 791–798 (1985).

    Article  CAS  PubMed  Google Scholar 

  67. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. & Hoffmann, J. A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973–983 (1996).

    Article  CAS  PubMed  Google Scholar 

  68. Reichhart, J. M. et al. Insect immunity: developmental and inducible activity of the Drosophila diptericin promoter. EMBO J. 11, 1469–1477 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Engstrom, Y. et al. κB-like motifs regulate the induction of immune genes in Drosophila. J. Mol. Biol. 232, 327–333 (1993).

    Article  CAS  PubMed  Google Scholar 

  70. Gay, N. J. & Keith, F. J. Drosophila Toll and IL-1 receptor. Nature 351, 355–356 (1991).

    Article  CAS  PubMed  Google Scholar 

  71. Nomura, N. et al. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res. 1, 27–35 (1994).

    Article  CAS  PubMed  Google Scholar 

  72. Taguchi, T., Mitcham, J. L., Dower, S. K., Sims, J. E. & Testa, J. R. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genomics 32, 486–488 (1996).

    Article  CAS  PubMed  Google Scholar 

  73. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997).

    Article  CAS  PubMed  Google Scholar 

  74. Mansell, A., Reinicke, A., Worrall, D. M. & O'Neill, L. A. The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-κB activation by TLR-4. FEBS Lett. 508, 313–317 (2001).

    Article  CAS  PubMed  Google Scholar 

  75. Poltorak, A., Ricciardi-Castagnoli, P., Citterio, A. & Beutler, B. Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc. Natl Acad. Sci. USA 97, 2163–2167 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Lien, E. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105, 497–504 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. da Silva, C. J., Soldau, K., Christen, U., Tobias, P. S. & Ulevitch, R. J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276, 21129–21135 (2001).

    Article  Google Scholar 

  78. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A. & Bazan, J. F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl Acad. Sci. USA 95, 588–593 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Chaudhary, P. M. et al. Cloning and characterization of two Toll/interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood 91, 4020–4027 (1998).

    CAS  PubMed  Google Scholar 

  80. Takeuchi, O. et al. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231, 59–65 (1999).

    Article  CAS  PubMed  Google Scholar 

  81. Du, X., Poltorak, A., Wei, Y. & Beutler, B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11, 362–371 (2000).

    CAS  PubMed  Google Scholar 

  82. Chuang, T. H. & Ulevitch, R. J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11, 372–378 (2000).

    CAS  PubMed  Google Scholar 

  83. Chuang, T. & Ulevitch, R. J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518, 157–161 (2001).

    Article  CAS  PubMed  Google Scholar 

  84. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11, 443–451 (1999).

    Article  CAS  PubMed  Google Scholar 

  85. Takeuchi, O. et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933–940 (2001).

    Article  CAS  PubMed  Google Scholar 

  86. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).

    Article  CAS  PubMed  Google Scholar 

  87. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115–122 (1999).

    Article  CAS  PubMed  Google Scholar 

  88. Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nature Immunol. 3, 196–200 (2002).

    Article  CAS  Google Scholar 

  89. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150 (1998).

    Article  CAS  PubMed  Google Scholar 

  90. Ozinsky, A. et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl Acad. Sci. USA 97, 13766–13771 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Takeuchi, O. et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10–14 (2002).

    Article  CAS  PubMed  Google Scholar 

  92. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–1103 (2001).

    Article  CAS  PubMed  Google Scholar 

  93. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738 (2001).

    Article  CAS  PubMed  Google Scholar 

  94. Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88- dependent signaling pathway. Nature Immunol. 3, 196–200 (2002).

    Article  CAS  Google Scholar 

  95. Ahmad-Nejad, P. et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958–1968 (2002).

    Article  CAS  PubMed  Google Scholar 

  96. Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777–1782 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Nagai, Y. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nature Immunol. 3, 667–672 (2002).

    Article  CAS  Google Scholar 

  98. Schromm, A. B. et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signalling. J. Exp. Med. 194, 79–88 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

B.B. is supported by a grant from the National Institutes of Health and by a grant from the Defense Advanced Projects Research Agency (DARPA). E.Th.R. is supported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. We thank I. Bendt, C. Alexander and G. Müller for typing this manuscript and for photographical work. We further thank A. Neschke for help in translating the Latin text of Fig. 1. This article is dedicated to our colleague and friend Jack Levin, Editor-in-Chief of the Journal of Endotoxin Research, on the occasion of his 70th birthday (11 October 2002).

Author information

Authors and Affiliations

  1. The Scripps Research Institute, La Jolla, 92037, California, USA

    Bruce Beutler

  2. Research Center, Borstel, D-23845, Borstel, Germany

    Ernst Th. Rietschel

Authors
  1. Bruce Beutler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ernst Th. Rietschel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce Beutler.

Related links

Related links

DATABASES

LocusLink

CD14

IL-1

IL-18

MD2

MyD88

TLR1

TLR2

TLR3

TLR4

TLR5

TLR6

TLR7

TLR8

TLR9

TNF

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beutler, B., Rietschel, E. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3, 169–176 (2003). https://doi.org/10.1038/nri1004

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nri1004

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing